Cycloplegic Delivery Investigation

This study has been completed.

First Received: May 9, 2007 Last Updated: July 1, 2008 History of Changes

Sponsored by:	Ohio State University
Information provided by:	Ohio State University
ClinicalTrials.gov Identifier:	NCT00472524

Purpose

The goal of this study is to compare the effectiveness of the administration of sequential drops, a combination drop and a combination spray for producing mydriasis and cycloplegia.

Condition	Intervention
Healthy	Procedure: Mydriasis/cycloplegia via different modes of administration

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Diagnostic, Non-Randomized, Open Label, Active Control, Single Group Assignment

Further study details as provided by Ohio State University:

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	8 Years to 30 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

patients ages 8 to 30 with best corrected acuity of 20/30 or better in both eyes at distance and near will be recruited.

Exclusion Criteria:

vision not correctable to 20/30 or better

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472524

Sponsors and Collaborators

Ohio State University

Investigators

Principal Investigator:

Marjean Kulp, OD, MS

Ohio State University

More Information

No publications provided

Study ID Numbers:	2003H0072
Study First Received:	May 9, 2007
Last Updated:	July 1, 2008
ClinicalTrials.gov Identifier:	NCT00472524 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Mydriatics
Healthy

ClinicalTrials.gov processed this record on May 06, 2009